Cargando…

ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer

Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jardé, Thierry, Kass, Lisa, Staples, Margaret, Lescesen, Helen, Carne, Peter, Oliva, Karen, McMurrick, Paul J., Abud, Helen E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569358/ https://www.ncbi.nlm.nih.gov/pubmed/26367378 http://dx.doi.org/10.1371/journal.pone.0138336

Ejemplares similares

Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes Following Chemotherapeutic Treatment
por: Engel, Rebekah M., et al.
Publicado: (2020)

Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
por: Koulis, Christine, et al.
Publicado: (2020)

Surgical outcome after standard abdominoperineal resection: A 15-year cohort study from a single cancer centre
por: Wilkins, S., et al.
Publicado: (2018)

Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells
por: Abud, Helen E., et al.
Publicado: (2021)

The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients
por: Yap, Raymond, et al.
Publicado: (2016)

SRSF3 shapes the structure of miR‐17‐92 cluster RNA and promotes selective processing of miR‐17 and miR‐20a
por: Ratnadiwakara, Madara, et al.
Publicado: (2023)

Role of lymph node yield and lymph node ratio in predicting outcomes in non‐metastatic colorectal cancer
por: Lee, C. H. A., et al.
Publicado: (2018)

Surgical Techniques for Abdominoperineal Resection for Rectal Cancer: One Size Does Not Fit All
por: Wilkins, Simon, et al.
Publicado: (2022)

Microarray profiling to analyze the effect of Snai1 loss in mouse intestinal epithelium
por: Hime, Gary R., et al.
Publicado: (2015)

Modeling colorectal cancer: A bio‐resource of 50 patient‐derived organoid lines
por: Engel, Rebekah M, et al.
Publicado: (2022)

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer
por: Baqar, Ali Riaz, et al.
Publicado: (2020)

A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem Cells
por: Nefzger, Christian M., et al.
Publicado: (2016)

Topical nifedipine for post-haemorrhoidectomy pain relief: randomized, prospective, double-blind trial protocol
por: Steen, Christopher J, et al.
Publicado: (2023)

Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
por: Lahlou, Hicham, et al.
Publicado: (2012)

A comparison of extracorporeal side to side or end to side anastomosis following a laparoscopic right hemicolectomy for colon cancer
por: Baqar, Ali Riaz, et al.
Publicado: (2022)

New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells
por: O'Brien, Carmel M., et al.
Publicado: (2017)

Factors affecting the post-operative outcomes in patients aged over 80 following colorectal cancer surgery
por: Yap, Raymond, et al.
Publicado: (2023)

RHAMM marks proliferative subpopulation of human colorectal cancer stem cells
por: Nakano, Michitaka, et al.
Publicado: (2023)

ErbB2 Dephosphorylation and Anti-Proliferative Effects of Neuregulin-1 in ErbB2-Overexpressing Cells; Re-evaluation of Their Low-Affinity Interaction
por: Wang, Ran, et al.
Publicado: (2013)

Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation
por: Zhu, Liqin, et al.
Publicado: (2008)

Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish
por: Janjuha, Sharan, et al.
Publicado: (2018)

Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids
por: Jardé, Thierry, et al.
Publicado: (2016)

Australasian ACPGBI risk prediction model for 30‐day mortality after colorectal cancer surgery
por: Wilkins, S., et al.
Publicado: (2020)

LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
por: Wang, Y, et al.
Publicado: (2013)

Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells
por: Bagnato, Paola, et al.
Publicado: (2017)

Molecular distinctions among ERBB2-overexpressing breast cancers
por: Jeffrey, SS
Publicado: (2005)

Kinase activity of ERBB3 contributes to intestinal organoids growth and intestinal tumorigenesis
por: Nguyen, Anh Thai‐Quynh, et al.
Publicado: (2019)

Intestinal stem cell aging signature reveals a reprogramming strategy to enhance regenerative potential
por: Nefzger, Christian M., et al.
Publicado: (2022)

Lrig1 controls intestinal stem cell homeostasis by negative regulation of ErbB signalling
por: Wong, Vivian W.Y., et al.
Publicado: (2012)

Marks of distinction : two hundred years of American drawings and watercolors from the Hood Museum of Art /
Publicado: (2005)

Preferential Antibody and Drug Conjugate Targeting of the ADAM10 Metalloprotease in Tumours
por: Yan, Hengkang, et al.
Publicado: (2022)

5-hydroxymethylcytosines regulate gene expression as a passive DNA demethylation resisting epigenetic mark in proliferative somatic cells
por: Wei, Alex, et al.
Publicado: (2023)

Two Cases of Proliferative Diabetic Retinopathy with Marked Sheathing of the Retinal Arteries following Vitrectomy
por: Nishikawa, Yuko, et al.
Publicado: (2017)

Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition
por: Raja, Srikumar M., et al.
Publicado: (2016)

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells
por: Valabrega, G, et al.
Publicado: (2003)

ErbB receptors and their growth factor ligands in pediatric intestinal inflammation
por: Frey, Mark R., et al.
Publicado: (2013)

Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets
por: Lavogina, Darja, et al.
Publicado: (2021)

Gpr125 Marks Distinct Cochlear Cell Types and Is Dispensable for Cochlear Development and Hearing
por: Sun, Haiying, et al.
Publicado: (2021)

Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
por: Irwin, Mary E., et al.
Publicado: (2013)

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases
por: Spencer, Kathryn S.R., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_v1ugtol8fgefs4i9hf1s687gqq